NKTR Competitors & Alternatives
Compare Nektar Therapeutics with similar stocks in the same industry
Biotechnology
NKTR
Main Stock$59.23
Tradestie Score
48
Market Cap
$1.12B
Revenue Growth
0.0%
Analyst Upside
+158.7%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MESO
Mesoblast Limited American Depositary Shares
|
$14.52
|
$2.08B | - | 55 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$16.24
|
$2.02B | 46.6 | 54 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$13.02
|
$2.01B | - | 54 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$32.26
|
$1.97B | - | 59 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$8.35
|
$1.92B | - | 56 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$88.95
|
$1.92B | - | 47 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$55.69
|
$1.90B | 324.2 | 58 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$31.27
|
$1.84B | - | 52 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$28.65
|
$1.81B | - | 60 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.72
|
$1.78B | - | 59 | Compare |
More NKTR Analysis
Data updated: Jun 03, 2026 | Industry: Biotechnology (SIC 2834)
224 stocks in this industry